We would like to thank the v-safe participants for their participation in the v-safe pregnancy registry and the members of the CDC COVID-19 Response Team for their support and contributions. We would also like to thank the members of the CDC v-safe COVID-19 Pregnancy Registry Team: Amena Abbas, M.P.H.1,2, Amanda Akosa, M.P.H.3, Dayna S. Alexander, Ph.D.4, Kathryn E. Arnold, M.D.3, Jamal Bankhead, Dr.P.H.5, Tabatha Barber, Ph.D.6, Amy Blum, M.H.S.A.7, Ellen Boundy, Sc.D.8, Virginia B. Bowen, PhD.9, Kailyn M. Brooks, M.P.H.2,10, Cheryl Broussard, Ph.D.3, Tara Brown, M.P.H.11, Veronica K. Burkel, M.P.H.3, Gyan Chandra, M.S.10, Karen Chang, Ph.D.12, Dena Cherry-Brown, M.P.H.3, Monica DiRienzo, M.A.13, Tuyen Do, B.S.C.S.14, Charise Fox, M.P.H.2,3, Julianne M. Gee, M.P.H.15, Robbie Gray, A.S.16, Caitlin J. Green, M.P.H.3, Jennifer Hamborsky, M.P.H.17, Anne M. Hause, Ph.D.15, Jennifer Hegle, M.P.H.18, Obehi Ilenikhena, M.P.H.19, Jessly Joy, M.P.H.20, Ashley Judge, M.P.H.2,3, Alaya Koneru, M.P.H.17, Zanie Leroy, M.D.21, Birook Mekonnen, M.P.H.2, 13, Anne Moorman, M.P.H.22, Pedro L. Moro, M.D.15, John F. Nahabedian III, M.S.3, Morgan Nail, B.S.2, 23, Andrea Neiman, Ph.D.1, Kimberly Newsome, M.P.H.13, Suzanne Newton, M.P.H. 3, Keydra Phillips Oladapo, Ph.D.5, Nicole S. Olgun, Ph.D.6, H. Pamela Pagano, Dr.P.H.10, Lakshmi Panagiotakopoulos, M.D.22, Youngjoo Park, M.P.H.2,3, Corrine Parker, Pharm.D.12, Kara Polen, M.P.H.3, Emmitt Rathore, B.S.3, Tom T. Shimabukuro, M.D.15, Penelope Strid, M.P.H.10, Jennifer M. Swanson, M.P.H.18, Ayzsa F. Tannis, M.P.H.2,3, Naomi K. Tepper, M.D.3, Letha Thomas, Ph.D.18, Lindsey A. Torre, M.S.P.H18, Emmy L. Tran, Pharm.D.3, Susanna L. Trost, M.P.H.2,10, Diana Valencia, M.S.3, Jennifer L. Wilkers, M.P.H.2, 10, Luke Yip, M.D.24, and Sarah Zohdy, Ph.D25. We would also like to thank Ronghui (Lily) Xu, Ph.D.26, and Margaret Honein, Ph.D.12, for their statistical analysis consultation. This project was supported in part by an appointment to the Research Participation Program at the Centers for Disease Control and Prevention administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and the Centers for Disease Control and Prevention.
1Division of Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, CDC; 2Oak Ridge Institute for Science and Education; 3Division of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, CDC; 4Division of Diabetes and Translation, National Center for Chronic Disease Prevention and Health Promotion, CDC; 5 Division of HIV/AIDS Prevention National Center for HIV/AIDS, Viral Hepatitis, STD, and TB prevention; 6Health Effects Laboratory Division, National Institute for Occupational Safety and Health, CDC; 7Division of Health Care Statistics, National Center for Health Statistics, CDC; 8Division of Nutrition, Physical Activity, and Obesity, National Center for Chronic Disease Prevention and Health Promotion, CDC; 9Division of Sexually Transmitted Disease Prevention, National Center for HIV/AIDS, Vital Hepatitis, STD and TB Prevention, CDC; 10Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion; 11Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, CDC; 12Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, CDC; 13Division of Human Development and Disability, National Center on Birth Defects and Developmental Disabilities, CDC; 14 Office of the Director, National Center for Emerging and Zoonotic Infectious Diseases, CDC; 15Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, CDC; 16Office of the Chief Operating Officer, Office of the Director, CDC; 17Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC; 18Division of Global HIV and TB, Center for Global Health, CDC; 19Division of Performance Improvement and Field Services, Center for State, Tribal, Local and Territorial Support, CDC;20Division of Analysis and Epidemiology, National Center for Health Statistics, CDC; 21Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, CDC; 22Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC; 23Division of Laboratory Sciences, National Center for Environmental Health, CDC; 24National Center for Environmental Health/Agency for Toxic Substances and Disease Registry, Office of Emergency Management, CDC; 25Division of Parasitic Disease Malaria, Center for Global Health, CDC; 26Department of Family Medicine and Public Health, Department of Mathematics, University of California San Diego.
Disclaimer: The findings and conclusions in this article are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention (CDC). Mention of a product or company name is for identification purposes only and does not constitute endorsement by the CDC or the FDA. All authors are U.S. government employees or U.S. government contractors and do not have any material conflicts of interest.
The authors have no conflicts of interest to disclose.